Dynamic movement of cytochrome c from mitochondria into cytosol and peripheral circulation in massive hepatic cell injury

Pediatr Int. 2004 Dec;46(6):685-92. doi: 10.1111/j.1442-200x.2004.01980.x.

Abstract

Background: In the process of apoptosis, it is known that the transition of cytochrome c from mitochondria into the cytosol occurs, and tumor necrosis factor (TNF)-alpha is one of the molecules responsible for this event. But in the state of hypercytokine induced by D-galactosamine (D-GaIN)/Lipopolysaccharide (LPS), the localization of cytochrome c is little known.

Methods: Rats were administrated with D-GaIN(700 mg/kg)/LPS(200 microg/kg). Blood and tissue samples were collected and examined for levels of pro-inflammatory cytokines, the apoptosis of liver cells, and the localization of cytochrome c.

Result: Before administration of D-GaIN/LPS, cytochrome c was definitely localized in the mitochondria. At 2 h after simultaneous administration of D-GaIN/LPS, cytochrome c had accumulated in the cytosol following abrupt increases of plasma TNF-alpha. Massive cell destruction due to apoptosis proved by Terminal deoxynucleo-tidyl transferase-mediated dUTP nick end labeling staining was observed in liver tissue 4 h later and markedly increased levels of cytochrome c were detected in the plasma 12 h after D-GaIN/LPS administration.

Conclusion: Liver injury induced by simultaneous administration of D-GaIN/LPS was closely associated with the production of TNF-alpha, and also with the dynamic movement of cytochrome c from the mitochondria into the cytosol, and then into the systemic circulation. The detection of plasma cytochrome c levels may be a useful clinical tool for the detection of apoptosis in vivo.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Biological Transport, Active
  • Blotting, Western
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cytochromes c / metabolism*
  • Cytosol / metabolism
  • Disease Models, Animal
  • Female
  • Galactosamine / pharmacology*
  • Hepatocytes / physiology*
  • Immunohistochemistry
  • In Situ Nick-End Labeling
  • Lipopolysaccharides / pharmacology*
  • Liver Failure / physiopathology
  • Mitochondria / metabolism*
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Sensitivity and Specificity
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Galactosamine
  • Cytochromes c